4basebio【4BB】銘柄情報

4basebio Plc (4BB) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

525.00

( - )

買値

500.00

売値

550.00

出来高

585

525.00 日の範囲 525.00

425.00 52 週間の範囲 1,000.00

時価総額

81.577M

前日終値

525.00

始値

525.00

時刻

500

525

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

1,665p

発行済株式数

15,538,518

配当利回り

PER

-5.05

1 株当たり利益 (EPS)

-1.09

歳入

1.69M

純利益

-16.91M

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a partial... 4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA for in vitro transcription processes that produce mRNA for use in vaccines and therapeutics; oeDNA, a linear, double stranded DNA for genome editing; osDNA, a DNA product that incorporates nucleotide modifications within the DNA backbone; and Hermes, a nanoparticle platform. The company also provides custom pegRNA and sgRNA manufacturing; and nanoparticle formulation services. Its products are used in mRNA vaccines and therapies, viral vectors, gene editing, DNA vaccines, and non-viral delivery applications. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is headquartered in Cambridge, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.4basebio.com

本社

Cambridge, United Kingdom

設立

2026

4basebio Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker 4BB. The last closing price for 4basebio was 525p. Over the last year, 4basebio shares have traded in a share price range of 425.00p to 1,000.00p.

4basebio currently has 15,538,518 shares in issue. The market capitalisation of 4basebio is £81.58 million. 4basebio has a price to earnings ratio (PE ratio) of -5.05.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	525	532.5	525	573	525	DE
4	-22.5	-4.1095890411	547.5	585	525	1275	542.7109473	DE
12	10	1.94174757282	515	585	425	1575	505.99590496	DE
26	-90	-14.6341463415	615	615	425	1493	531.73506959	DE
52	-460	-46.7005076142	985	1000	425	1339	659.26614366	DE
156	-50	-8.69565217391	575	1820	425	2168	1016.75740764	DE
260	68	14.8796498906	457	1820	400	2275	843.26046246	DE